CCR2 and Cognitive impairment: When performing site-directed pre-injection on rats with RS504393, a CCR2 antagonist, the drug abrogated surgery-induced cognitive deficits and abolished pro-inflammatory microglial polarization and subsequent neuronal loss [38].